Cargando…
The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland
Trisomy 21 (T21) is associated in 40–45% of cases with heart defects, most commonly shunt lesions. These defects, if not repaired, can lead to irreversible shunt-induced pulmonary hypertension (i.e. Eisenmenger syndrome [ES]). In ES patients, intracardiac repair is no longer possible, but selective...
Autores principales: | Johannes, Judith, Greutmann, Matthias, Tobler, Daniel, Bouchardy, Judith, Stambach, Dominik, Wustmann, Kerstin, Schwitz, Fabienne, Schwerzmann, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287318/ https://www.ncbi.nlm.nih.gov/pubmed/30338722 http://dx.doi.org/10.1177/2045894018811147 |
Ejemplares similares
-
Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts
por: Ruperti-Repilado, Francisco Javier, et al.
Publicado: (2021) -
Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
por: Thomet, Corina, et al.
Publicado: (2023) -
Arrhythmic Burden of Adult Survivors With Repaired Total Anomalous Pulmonary Venous Connection
por: Touray, Mariama, et al.
Publicado: (2022) -
Gender-related differences in self-reported dental care in adults with congenital heart disease at increased risk of infective endocarditis
por: Schmidt, Susann, et al.
Publicado: (2017) -
Tracheal Stenosis and Congenital Heart Disease in Trisomy 21
por: Kylat, Ranjit I
Publicado: (2019)